Elite Pharmaceuticals: director Barry H Dash bought 100,000 shares

What happened

• Barry H Dash, director, bought 100,000 shares at $0.26 per share on Oct 9, 2026 for $25,980, reported as an open market or private purchase (P) on the Form 4.

Key details

• Transaction date and price: Oct 9, 2026 — 100,000 shares at $0.26.
• Total value reported: $25,980.
• Transaction type: open market or private purchase (code P).
• Shares owned after the transaction: not reported in the supplied filing.
• Footnotes or plans: no footnotes, 10b5-1 plan, tax withholding or other explanatory notes are shown in the supplied filing.
• Filing date and timeliness: Form 4 filed Oct 19, 2026; the filing lists the transaction date as Oct 9, 2026. The supplied data does not include a timeliness flag.

Why it may matter

• This was a purchase reported as P (not an option exercise, award, or gift) and is recorded as an open market or private purchase in the filing.
• A filing does not show why the insider traded or why the company acted.